Professor Sir Martin Landray

Professor Sir Martin Landray is a Senior Research Fellow, Green Templeton College and Professor of Medicine & Epidemiology, Nuffield Department of Population Health, University of Oxford. He was founding Deputy Director of the Big Data Institute until 2022. He is also Chief Executive of Protas, a not-for-profit company that focuses on advancing the design and delivery of highly efficient randomised trials of treatments for major public health conditions.

His work leading large, randomised trials of treatments for common diseases uses innovative approaches to improve trial quality and efficiency. He has conducted a series of definitive trials in cardiovascular and kidney disease that have changed regulatory licenses and clinical practice. Since March 2020, he has co-led the RECOVERY trial, enrolling over 49,000 patients with COVID-19 and publishing definitive results for 15 treatments which have changed clinical practice and estimated to have prevented over 1 million deaths worldwide.

In addition, he has played an international role in driving forwards improvements in the regulations that govern clinical trials, working with national and international organisations (including FDA, EMA, MHRA, ICH, WHO, MRC, NIHR and European Society of Cardiology). He was a lead contributor to the G7 Clinical Trials Charter and the 100 Days Mission for Pandemic Preparedness. Under his leadership, the Good Clinical Trials Collaborative (supported by Wellcome and Gates) coordinated the production of new principles-based guidelines for clinical trials which were adopted by the World Health Organization and included in the WHO Best Practices for Clinical Trials in 2024.

In June 2021, he was knighted for services to public health and science.

Contact: martin.landray@ndph.ox.ac.uk
PA: penelope.rodgers@ndph.ox.ac.uk